Uromeda s.r.o.
- Address
- Vinicni 4049/235, Zidenice, 615 00 Brno, Czechia
Uromeda s.r.o. - Urinary Tract and E. coli Infection Research
Uromeda s.r.o. is a specialized clinical research center focused on urological infections and their serious complications in older adults. The facility conducts advanced vaccine trials targeting the prevention of severe bacterial infections, particularly those affecting patients with recurrent urinary tract conditions.
- Prevention of invasive extraintestinal pathogenic E. coli disease in vulnerable populations
- Vaccine efficacy studies for recurrent urinary tract infection patients
- Infectious disease prevention research in adults aged 60 years and older
The center demonstrates expertise in evaluating novel vaccine candidates such as ExPEC9V, specifically designed to prevent invasive E. coli disease (IED) with microbiological confirmation from blood or sterile sites. Their research targets multiple O-serotypes of E. coli, addressing a critical need for preventive strategies in older adults with histories of urinary tract infections, who face elevated risks of life-threatening systemic infections.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Uromeda s.r.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Evaluation of ExPEC9V Vaccine for Preventing Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60+ with Prior Urinary Tract Infection | Janssen Vaccines & Prevention B.V. | Phase III | Not Recruiting | Feb 2022 | Aug 2025 |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ecoo15 | 1 | Unknown | 2022-02-09 | 2022-02-09 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.